Jaap Bremer

T: +31 70 376 06 25
E: jaap.bremer@barentskrans.nl
View Jaap Bremer on LinkedIn

Jaap’s practice focuses on Intellectual Property litigation, in particular with respect to patents, trademarks and advertising. Jaap has extensive experience in infringement and invalidity litigation, as well as in parallel import, anti-counterfeiting and customs enforcement matters, particularly for clients in the pharma & life sciences, food & beverage and consumer products industries. He also regularly advises clients in non-contentious matters, including negotiation and drafting of licence and coexistence agreements.

Selected directory listings

Clients value his “very practical advice, commercial awareness and strong technical knowledge.” Chambers Global & Europe 2019

‘The knowledge of a professor and the attitude of a lean, mean business lawyer’ – Legal 500, 2018

Sources admire his “high expertise paired with responsiveness, creativity and pragmatism,” and appreciate that he “always has the client’s interests in mind.” – Chambers Global & Europe, 2018

Professional activities

Member of Editorial Board EPLAW Patent Blog
Active member of the International Trademark Association (INTA)
Member of various professional associations, including EPLAW, PTMG, LES, BMM, VFenR, VvRr and MARQUES.

News and publications

National Patent Litigation – The Netherlands

In Les Nouvelles, the journal of Licensing Executives Society International (LESI) distributed quarterly to all members worldwide, an article co-written by partner IE & technology Jaap Bremer was published in December 2018. The article ‘National Patent Litigation – The Netherlands’ provides an overview of the most important aspects of patent litigation in the Netherlands. The
Read more ›

Pharma update: Indirect infringement of Swiss type claims is possible

In its judgment of 3 November 2017 in the case between Merck Sharp & Dohme (‘MSD’) and Teva, the Dutch Supreme Court ruled (ECLI:NL:HR:2017:2807) that indirect infringement of a ‘Swiss type’ second medical use patent claim is possible. In addition, the Supreme Court found that there is no difference in the scope of protection of second
Read more ›
More from this specialist